The following is brief analysis, summary and tracked changes in a copy of the New Hampshire Board of Medicine (BOM) Med 502 rules relating to the prescribing of opioids for chronic pain resulting from HB 1639 and BOM revised rules #13248 approved by JLCAR, effective 8-6-21. Analysis Having assisted chronic pain patients in the development […]
https://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.png00NHMShttps://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.pngNHMS2022-03-18 15:14:012022-03-18 15:16:18Analysis & Summary of Revised NH Board of Medicine Rules for Opioid Prescribing for Chronic Pain
Key Points and Recommendations: Providers should continue to refer to the NIH and IDSA treatment guidelines for decisions regarding the multiple outpatient therapies available to treat patients with COVID-19. The two oral antiviral medications Paxlovid and molnupiravir are now being allocated to certain commercial pharmacies in New Hampshire, and are available through routine prescribing. Molnupiravir […]
https://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.png00NHMShttps://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.pngNHMS2022-03-14 15:44:172022-03-14 15:46:08NHHS Health Alert - COVID-19 Pandemic, Update # 58 Paxlovid and Molnupiravir Distribution
On August 31, 2021, NH DHHS issued a health alert update on the recall of LeadCare blood lead tests.Key Points and Recommendations: Magellan Diagnostics, Inc. has expanded their product recall involving the LeadCare ® blood test kits. This expanded COOR-LO recall includes LeadCare® II Blood Test Kits lots: 2012M (Sublots -08, -09, -10, -11, -12, -13, […]
https://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.png00NHMShttps://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.pngNHMS2021-08-31 18:27:492021-09-13 17:01:31Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results, Update #1: Expanded Recall to Include all LeadCare® II Testing Supply Kits
Update # 44 mRNA COVID-19 Vaccine 3rd Dose Recommendations On August 13, 2021, NH DHHS issued a health alert on mRNA COVID-19 vaccine 3rd dose recommendations. Key Points and Recommendations: On August 12th, the U.S. Food and Drug Administration (FDA) authorized use of a 3rd dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for certain immunocompromised persons. The Emergency Use Authorization (EUA) amendment […]
On July 2, 2021, NH DHHS issued a health alert regarding NH’s lowering of the pediatric blood lead action level to 5 mcg/dL Key Points and Recommendations: Effective July 1, 2021, NH RSA 130-A, Lead Paint Poisoning Prevention and Control, lowers the NH public health action level for children with elevated blood lead levels (BLL) to 5 mcg/dL; […]
https://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.png00NHMShttps://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.pngNHMS2021-07-02 15:48:062021-09-13 16:58:10NH Lowers Pediatric Blood Lead Action Level to 5 mcg/dL and Changes Elevated Blood Lead Level (BLL) Test Confirmation Schedule
The New Hampshire medical community urges individuals, communities, schools and businesses to continue to follow Centers for Disease Control and NH Division of Public Health Services guidelines that highlight the efficacy of wearing masks in slowing the community transmission of COVID-19 in New Hampshire, in conjunction with other prevention measures, until: 1) COVID-19 vaccination levels reach […]
https://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.png00NHMShttps://nhmedicalsociety.com/wp-content/uploads/2021/09/nhms-logo-3-1.pngNHMS2021-04-20 16:26:202021-09-20 13:16:03NH Medical Society Statement on Continued Mask Wearing during the COVID-19 Pandemic
Analysis & Summary of Revised NH Board of Medicine Rules for Opioid Prescribing for Chronic Pain
/in Latest News /by NHMSThe following is brief analysis, summary and tracked changes in a copy of the New Hampshire Board of Medicine (BOM) Med 502 rules relating to the prescribing of opioids for chronic pain resulting from HB 1639 and BOM revised rules #13248 approved by JLCAR, effective 8-6-21. Analysis Having assisted chronic pain patients in the development […]
NHHS Health Alert – COVID-19 Pandemic, Update # 58 Paxlovid and Molnupiravir Distribution
/0 Comments/in Latest News /by NHMSKey Points and Recommendations: Providers should continue to refer to the NIH and IDSA treatment guidelines for decisions regarding the multiple outpatient therapies available to treat patients with COVID-19. The two oral antiviral medications Paxlovid and molnupiravir are now being allocated to certain commercial pharmacies in New Hampshire, and are available through routine prescribing. Molnupiravir […]
Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results, Update #1: Expanded Recall to Include all LeadCare® II Testing Supply Kits
/in Latest News /by NHMSOn August 31, 2021, NH DHHS issued a health alert update on the recall of LeadCare blood lead tests.Key Points and Recommendations: Magellan Diagnostics, Inc. has expanded their product recall involving the LeadCare ® blood test kits. This expanded COOR-LO recall includes LeadCare® II Blood Test Kits lots: 2012M (Sublots -08, -09, -10, -11, -12, -13, […]
Coronavirus Disease 2019 (COVID-19) Outbreak
/in Latest News /by NHMSUpdate # 44 mRNA COVID-19 Vaccine 3rd Dose Recommendations On August 13, 2021, NH DHHS issued a health alert on mRNA COVID-19 vaccine 3rd dose recommendations. Key Points and Recommendations: On August 12th, the U.S. Food and Drug Administration (FDA) authorized use of a 3rd dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for certain immunocompromised persons. The Emergency Use Authorization (EUA) amendment […]
NH Lowers Pediatric Blood Lead Action Level to 5 mcg/dL and Changes Elevated Blood Lead Level (BLL) Test Confirmation Schedule
/in Latest News /by NHMSOn July 2, 2021, NH DHHS issued a health alert regarding NH’s lowering of the pediatric blood lead action level to 5 mcg/dL Key Points and Recommendations: Effective July 1, 2021, NH RSA 130-A, Lead Paint Poisoning Prevention and Control, lowers the NH public health action level for children with elevated blood lead levels (BLL) to 5 mcg/dL; […]
NH Medical Society Statement on Continued Mask Wearing during the COVID-19 Pandemic
/in Latest News /by NHMSThe New Hampshire medical community urges individuals, communities, schools and businesses to continue to follow Centers for Disease Control and NH Division of Public Health Services guidelines that highlight the efficacy of wearing masks in slowing the community transmission of COVID-19 in New Hampshire, in conjunction with other prevention measures, until: 1) COVID-19 vaccination levels reach […]